The present study focuses on the chemical composition of the ethyl acetate organic fraction derived from cell-free culture of thermophilic Bacillus licheniformis MK027019 by GC-MS. In addition, the antibacterial activity of the organic fraction against two multidrug-resistant microorganisms is tested using the Radial Diffusion Assay technique. GC-MS analysis revealed that thermophilic B. licheniformis MK027019 produced five major groups of secondary metabolites based on their retention time, molecular formula and molecular weight. These groups were: [Germacrene-D: 14.70%], saturated hydrocarbon [Eicosane: 12.13%, Heneicosane: 3.17%], fatty acid methyl ester [hexadecanoic acid methyl ester: 6.51%, eicosanoic acid methyl ester: 0.78%], alkane [n-Tridecane: 4.39%] and quinoline derivative [8-Phenyl-isoquinoline: 3.51%]. This organic fraction is effective against the multidrug-resistant bacterium Pseudomonas aeruginosa. The presence of Germacrene-D and quinoline derivative are significant in this finding, and to our knowledge, this is the first time these compounds have been detected in thermophilic Bacillus licheniformis.
We are working on a new version of the website! To complete the upgrade, Sciforum will be unavailable on Saturday 18 July from 09:00 to 15:00 CEST. Thank you for your understanding.
Previous Article in event
Previous Article in session
Next Article in event
Next Article in session
Thermophilic Bacillus licheniformis MK027019 as a source of Germacrene-D and quinoline derivatives exhibiting antibacterial activity against multidrug-resistant bacteria.
Published:
01 November 2022
by MDPI
in 8th International Electronic Conference on Medicinal Chemistry
session Biomolecules as therapeutics
https://doi.org/10.3390/ECMC2022-13180
(registering DOI)
Abstract:
Keywords: Thermophilic Bacillus licheniformis; ethyl acetate organic fraction; GC–MS; antibacterial activity; Multidrug resistante bacteria; Germacrene-D; quinoline derivate.
Comments on this paper
DEROUICHE Salima
1 November 2022
It's very important work
